223 related articles for article (PubMed ID: 17671893)
21. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.
Searle F; Gac-Breton S; Keane R; Dimitrijevic S; Brocchini S; Sausville EA; Duncan R
Bioconjug Chem; 2001; 12(5):711-8. PubMed ID: 11562189
[TBL] [Abstract][Full Text] [Related]
22. Macromolecular HPMA-based nanoparticles with cholesterol for solid-tumor targeting: detailed study of the inner structure of a highly efficient drug delivery system.
Filippov SK; Chytil P; Konarev PV; Dyakonova M; Papadakis C; Zhigunov A; Plestil J; Stepanek P; Etrych T; Ulbrich K; Svergun DI
Biomacromolecules; 2012 Aug; 13(8):2594-604. PubMed ID: 22793269
[TBL] [Abstract][Full Text] [Related]
23. A novel α
Wang F; Li L; Sun W; Li L; Liu Y; Huang Y; Zhou Z
J Drug Target; 2018 Mar; 26(3):231-241. PubMed ID: 28792244
[TBL] [Abstract][Full Text] [Related]
24. N-(2-Hydroxypropyl)methacrylamide-based polymer conjugates with pH-controlled activation of doxorubicin for cell-specific or passive tumour targeting. Synthesis by RAFT polymerisation and physicochemical characterisation.
Chytil P; Etrych T; Kříž J; Subr V; Ulbrich K
Eur J Pharm Sci; 2010 Nov; 41(3-4):473-82. PubMed ID: 20696244
[TBL] [Abstract][Full Text] [Related]
25. Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance.
Braunová A; Kostka L; Sivák L; Cuchalová L; Hvězdová Z; Laga R; Filippov S; Černoch P; Pechar M; Janoušková O; Šírová M; Etrych T
J Control Release; 2017 Jan; 245():41-51. PubMed ID: 27871991
[TBL] [Abstract][Full Text] [Related]
26. HPMA copolymer-doxorubicin-gadolinium conjugates: synthesis, characterization, and in vitro evaluation.
Zarabi B; Nan A; Zhuo J; Gullapalli R; Ghandehari H
Macromol Biosci; 2008 Aug; 8(8):741-8. PubMed ID: 18484565
[TBL] [Abstract][Full Text] [Related]
27. Synergistic action of doxorubicin bound to the polymeric carrier based on N-(2-hydroxypropyl)methacrylamide copolymers through an amide or hydrazone bond.
Ríhová B; Etrych T; Sírová M; Kovár L; Hovorka O; Kovár M; Benda A; Ulbrich K
Mol Pharm; 2010 Aug; 7(4):1027-40. PubMed ID: 20524698
[TBL] [Abstract][Full Text] [Related]
28. Bloodstream Stability Predetermines the Antitumor Efficacy of Micellar Polymer-Doxorubicin Drug Conjugates with pH-Triggered Drug Release.
Chytil P; Šírová M; Kudláčová J; Říhová B; Ulbrich K; Etrych T
Mol Pharm; 2018 Sep; 15(9):3654-3663. PubMed ID: 29543465
[TBL] [Abstract][Full Text] [Related]
29. FRET-trackable biodegradable HPMA copolymer-epirubicin conjugates for ovarian carcinoma therapy.
Yang J; Zhang R; Radford DC; Kopeček J
J Control Release; 2015 Nov; 218():36-44. PubMed ID: 26410808
[TBL] [Abstract][Full Text] [Related]
30. Binding and cytotoxicity of HPMA copolymer conjugates to lymphocytes mediated by receptor-binding epitopes.
Tang A; Kopeiková P; Kopeckevá J
Pharm Res; 2003 Mar; 20(3):360-7. PubMed ID: 12669954
[TBL] [Abstract][Full Text] [Related]
31. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
[TBL] [Abstract][Full Text] [Related]
32. N-(2-Hydroxypropyl)methacrylamide-Based Linear, Diblock, and Starlike Polymer Drug Carriers: Advanced Process for Their Simple Production.
Koziolová E; Kostka L; Kotrchová L; Šubr V; Konefal R; Nottelet B; Etrych T
Biomacromolecules; 2018 Oct; 19(10):4003-4013. PubMed ID: 30180562
[TBL] [Abstract][Full Text] [Related]
33. Two-step fluorescence screening of CD21-binding peptides with one-bead one-compound library and investigation of binding properties of N-(2-hydroxypropyl)methacrylamide copolymer-peptide conjugates.
Ding H; Prodinger WM; Kopecek J
Biomacromolecules; 2006 Nov; 7(11):3037-46. PubMed ID: 17096529
[TBL] [Abstract][Full Text] [Related]
34. HPMA copolymer-aminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines.
Greco F; Vicent MJ; Penning NA; Nicholson RI; Duncan R
J Drug Target; 2005; 13(8-9):459-70. PubMed ID: 16332571
[TBL] [Abstract][Full Text] [Related]
35. DNA delivery systems based on complexes of DNA with synthetic polycations and their copolymers.
Oupický D; Konák C; Ulbrich K; Wolfert MA; Seymour LW
J Control Release; 2000 Mar; 65(1-2):149-71. PubMed ID: 10699278
[TBL] [Abstract][Full Text] [Related]
36. Biorecognition of HPMA copolymer-adriamycin conjugates by lymphocytes mediated by synthetic receptor binding epitopes.
Omelyanenko V; Kopecková P; Prakash RK; Ebert CD; Kopecek J
Pharm Res; 1999 Jul; 16(7):1010-9. PubMed ID: 10450924
[TBL] [Abstract][Full Text] [Related]
37. Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targeting.
Etrych T; Strohalm J; Chytil P; Černoch P; Starovoytova L; Pechar M; Ulbrich K
Eur J Pharm Sci; 2011 Apr; 42(5):527-39. PubMed ID: 21392579
[TBL] [Abstract][Full Text] [Related]
38. Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates.
Luo Y; Bernshaw NJ; Lu ZR; Kopecek J; Prestwich GD
Pharm Res; 2002 Apr; 19(4):396-402. PubMed ID: 12033370
[TBL] [Abstract][Full Text] [Related]
39. Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models.
Shamay Y; Golan M; Tyomkin D; David A
J Control Release; 2016 May; 229():192-199. PubMed ID: 27001892
[TBL] [Abstract][Full Text] [Related]
40. Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting.
Etrych T; Chytil P; Mrkvan T; Sírová M; Ríhová B; Ulbrich K
J Control Release; 2008 Dec; 132(3):184-92. PubMed ID: 18534705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
